Navigation Links
Sangamo BioSciences Reports First Quarter 2009 Financial Results
Date:4/29/2009

pared to $11.6 million for the same period in 2008.

Net interest and other income was $0.2 million for the first quarter of 2009, compared to $0.8 million for the same period in 2008. The decrease was due to lower average investment balances and lower interest rates.

First Quarter 2009 Highlights

  • Sangamo and its collaborators at the University of Pennsylvania opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS. The study is an open-label Phase 1 clinical trial designed to evaluate the safety and tolerability of a single infusion of SB-728-T, autologous (a patient's own) CD4+ T cells genetically modified at the CCR5 gene by CCR5-specific zinc finger DNA-binding protein nucleases (ZFNs). A total of twelve subjects with HIV will be enrolled in this trial in two treatment cohorts. In an animal model of HIV infection, SB-728-T has been shown to lead to an increase in CD4+ T-cell counts, a reduction in viral load and expansion of CCR5-modified T-cells, suggesting resistance to HIV. CCR5 is a co-receptor that enables HIV to enter and infect cells of the immune system. Individuals carrying a natural mutation of their CCR5 gene, CCR5-delta32, are highly resistant to infection by HIV. Brief exposure of cells to Sangamo's ZFNs results in the permanent disruption of the CCR5 gene. This trial is the first zinc finger nuclease therapeutic study in humans. Individuals interested in participating in this trial should visit http://www.clinicaltrials.gov/
  • Sangamo BioSciences, Inc. and its plant agriculture partner Dow AgroSciences announce publication in Nature of the successful application of ZFP technology for the efficient generation of maize plants with multiple, commercia
    '/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
3. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
4. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
5. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
6. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
7. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
8. Anaptys Biosciences Raises Over $33 Million in Series B Financing
9. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
10. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
11. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... 28, 2015 "Necrorun" was featured on ... a look at the latest and coolest applications on ... the host of NewsWatch and technology expert, conducted the ... an entertaining endless runner game with knights, nature, and ... released in 2009, according to Eurogamer. The popularity of ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Thousands ... devices manufactured by C.R. Bard, Inc. continue to ... U.S. District Court, Southern District of West Virginia, ... serving on the Plaintiffs’ Steering Committee. According ... has granted certain defendants named in those lawsuits ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 India ... coverage is made available to all visitors who purchase ... immediately. All members are encouraged to purchase the insurance ... avoid lack of proper coverage for pre-existing medical conditions. ... one or two medical conditions with serious consequences to ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Pitching speed, ... a history of shoulder and elbow injuries, according to new ... Medicine’s ( AOSSM ) Specialty Day. , “Our findings indicate ... a 20% increase in likelihood of a history of injury, ... with a 12% increase likelihood of a history of injury, ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... JUNE 23, 2008 , LOW SOCIOECONOMIC STATUS INCREASES RISK ... low socioeconomic status (SES) have more advanced cancers at diagnosis, ... dying in the five years following cancer diagnosis, according to ... August 1, 2008 issue of CANCER , a peer-reviewed ...
... Family Special Delivery Unit at The Children,s,Hospital of ... prenatally diagnosed birth defects, PHILADELPHIA, June 22 ... The Children,s Hospital of Philadelphia for,the 12th Annual ... who have been followed by the Center for ...
... gear and preparation can prevent unnecessary accidents, experts say ... simple safety precautions can greatly reduce the risk of ... doing summer sports and recreational activities, says the American ... about 319,000 sports-related head injuries treated in U.S. hospital ...
... calling on Louisiana Governor Jindal to veto a bill ... 312 was quietly,pushed through the legislature by PR firms ... asking Jindal to use his veto in,the interest of ... they were not., Fluoride is added to water ...
... those under 80, could ease expected worldwide shortfall of supplies ... product called HBOC-201 proved safe and effective in a six-week ... , In all, 688 patients, ages 18 and older, who ... blood (about one pint) or an equivalent one unit (65 ...
... Verathon(R) (formerly,Diagnostic Ultrasound Corp.), the maker of ... today the,company,s selection, for the second year in ... Work For" in Washington State by Washington CEO ... was ranked as the 4th "Best Company To ...
Cached Medicine News:Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 2Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 3Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 4Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 5Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 2Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 3Health News:Head Injuries All Too Common in Summer Play 2Health News:Professionals Ask Governor Jindal to Veto Unfair Fluoridation Bill 2Health News:Blood Substitute Found Safe in Large Phase III Trial 2Health News:Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine 2
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... for the blind, visually impaired and elderly. The ... empower these individuals to lead more independent, productive and ... Recognition Technology which will allow users to identify objects ... expanding, as well as create customized object databases for ...
(Date:3/27/2015)... 2015 /CNW Telbec/ - Russell Williams , President ... (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the fiscal ... the biopharmaceutical industry. However, the association is concerned about ... commend the government,s intent to strive for a balanced ... promote Quebec,s economic development is ...
(Date:3/27/2015)... VICTORIA, Texas , March 27, 2015  Victoria Vein ... removal services with the Astanza Duality laser in ... of vein disease as well as advanced laser treatments for ... are entering the tattoo industry to provide more services for ... Surgery has helped many Victoria residents ...
Breaking Medicine Technology:VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2
... 21 CareFusion (NYSE: CFN ), a ... release first quarter fiscal 2011 results on Tuesday, Nov. ... York Stock Exchange. (Logo:   http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) ... company will host a webcast and conference call on ...
... PharmAthene, Inc. (NYSE Amex: ... biological and chemical threats, announced today that the Company,s ... the position of President and Chief Executive Officer, effective ... Chief Executive Officer in May 2010, and prior thereto ...
Cached Medicine Technology:CareFusion Will Host an Earnings Conference Call on Nov. 2 to Discuss the Results for the First Quarter Fiscal 2011 2PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 2PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 3
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
... The ACCU-Beam® line of Surgical Microscope ... splitters, objective lenses, fiber optic cables, ... 35mm Photo Adaptor attaches directly to ... adaptors are used to mount the ...
Inquire...
Medicine Products: